scholarly journals Can the Use of Earrings Cause Eye Pain?

2018 ◽  
Vol 3 (3) ◽  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Vision Loss ◽  
Medical Condition ◽  
Causative Factor ◽  
Ocular Pain ◽  
Eye Pain ◽  
Eye Infection ◽  
Human Ear ◽  
Pain Symptoms

Introduction: Eye pain can occur on the surface of your eye or within your eye’s deeper structures. Severe eye pain especially accompanied by any degree of vision loss may be a signal that you have a serious medical condition. Eye pain that’s on the surface of your eye might be described as itching, burning or shooting pain. Surface eye pain is often related to a foreign object in your eye, an eye infection, or anything that irritates or inflames the membrane covering the surface of your eye. You might describe eye pain originating deeper within your eye as throbbing or aching [1]. Purpose: The purpose of this study is to demonstrate that the use of earrings can be a causative factor of eye pain. Methods: A reading of the location of the eye in the human ear was carried out through a map showing the location of the organs according to Traditional Chinese Medicine. Results: Over two reports of clinical cases of patients with ocular pain at the time of the consultation or the acupuncture session, there was almost immediate improvement of ocular pain symptoms after removal of the earrings bilaterally. Conclusion: The use of earrings, which are usually above the eye point, according to Traditional Chinese Medicine, could be the cause of eye pain, based on these two clinical reports.

scholarly journals Mingjing granule, a traditional Chinese medicine in the treatment of neovascular age-related macular degeneration: study protocol for a randomized controlled trial

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Yamin Li ◽  
Lina Liang ◽  
Torkel Snellingen ◽  
Kai Xu ◽  
Yun Gao ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Macular Degeneration ◽  
Vision Loss ◽  
Age Related Macular Degeneration ◽  
Case Report Form ◽  
Link Type ◽  
Anti Vegf ◽  
Age Related ◽  
Function Test

Abstract Background Neovascular age-related macular degeneration (nAMD) is the most common cause of irreversible vision loss and blindness among the older people aged 50 and over. Although anti-vascular endothelial growth factor (anti-VEGF) therapies have resulted in improving patient outcomes, there are limitations associated with these treatments. In China, traditional Chinese medicine (TCM) has been used to treat eye diseases for more than 2000 years. Previous studies have shown that TCM may be beneficial for nAMD patients. However, explicit evidence has not been obtained. The purpose of the present trial is to examine the efficacy and safety of the Mingjing granule, a compound Chinese herbal medicine, for nAMD patients. Methods/design This is a double-blind, placebo-controlled, randomized trial of Mingjing granule as an add-on to intravitreous ranibizumab for nAMD. One hundred eighty nAMD patients from six hospitals in China will be enrolled according to the inclusion and exclusion criteria and randomly allocated into two groups, 90 in each. All participants will receive a 24-week treatment and then be followed up for another 24 weeks. The primary outcome is the mean change of best-corrected visual acuity at week 24 and 48 as compared to the baseline. The secondary outcomes include mean change in central retinal thickness, area of retinal hemorrhage and exudation, and TCM syndrome score, mean number of intravitreal ranibizumab injection, and total cost of the treatment. Indexes of safety include blood regular test, urine regular test, liver function test, renal function test, and electrocardiogram from baseline to weeks 24 and 48. Qualitative control and some standard operating processes will be formed throughout the trial. Any ocular or systemic adverse events will be treated suitably, and related data will be recorded accurately and completely in the case report form. Discussion Based on previous empirical and animal laboratory studies, this study will address the question of whether Mingjing granule could contribute to improving efficacy, safety, and efficiency with need for fewer intravitreal injections of anti-VEGF, improving compliance and visual outcomes in the management of persons with nAMD. Trial registration Chinese Clinical Trial Registry (http://www.chictr.org.cn), ChiCTR2000035990. Registered on 21 August 2020.

scholarly journals Evaluation of the Therapeutic Effect of Traditional Chinese Medicine on Osteoarthritis: A Systematic Review and Meta-Analysis

2020 ◽  
Vol 2020 ◽  
pp. 1-23
Author(s):  
Lin Wang ◽  
Xiao-Fei Zhang ◽  
Xue Zhang ◽  
Dong-Yan Guo ◽  
Yu-Wei Duan ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Therapeutic Effect ◽  
Clinical Symptoms ◽  
Meta Analysis ◽  
Effective Rate ◽  
Control Group ◽  
Inflammatory Factor ◽  
Pain Symptoms ◽  
Experimental Group

Background. Osteoarthritis (OA) is a common degenerative disease of bone and joint characterized by the damage of articular cartilage and hypertonia, which often occurs in the middle-aged and elderly. Traditional Chinese medicine (TCM) therapy, including acupuncture (ACU), oral administration, and external use of traditional Chinese medicines (TCMs), can significantly improve the therapeutic effect on OA and reduce the occurrence of side effects. We provide a latest meta-analysis on the treatment of OA with TCM. Materials and Methods. In the electronic database, appropriate articles without language restrictions on keywords were selected until August 1, 2019. All trajectories are screened according to certain criteria. The quality of qualified research was also assessed. We have made a detailed record of the results of the measurement. Meta-analysis was carried out with Revman 5.3 software. Results. Forty-four articles involving 4014 patients (2012 cases in the experimental group and 2002 cases in the control group) with OA were selected. This article focuses on the study of the treatment of OA by using the general mode of TCM. The quality evaluation included in the study was evaluated independently according to the Cochrane intervention system evaluation manual. In this meta-analysis, 68.18% of the literature correctly described the conditions for the generation of random assignment sequences, only 6.82% of the literature correctly mentioned the hidden details of allocation, and all studies mentioned randomly assigned participants. Compared with Western medicine, the total effective rate (TER) of OA treatment in TCM was significantly increased and the recurrence rate (RR) was significantly decreased ( P < 0.00001 ). In addition, the experimental group was also superior to the control group in terms of the indicators of joint activity function, inflammatory factor content, and various indicators affecting bone metabolism. It can be showed by the network analysis diagram that Aconiti Radix, Achyranthis Bidentatae Radix, and other TCMs can inhibit inflammatory stimulation and relieve the pain symptoms of patients with OA. ACU at Yinlingquan, Xiyan, and other acupoints can effectively improve the clinical symptoms of patients with OA. Conclusion. TCM therapy in treatment of patients with OA could effectively restore joint function, enhance the TER, and reduce RR. However, the results of this study should be handled with care due to the limitations existing. Some rigorous randomized controlled trials (RCTs) are needed to confirm these findings.

scholarly journals Improvement of skin lesions in corticosteroid withdrawal-associated severe eczema by multicomponent traditional Chinese medicine therapy

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Serife Uzun ◽  
Zixi Wang ◽  
Tory A. McKnight ◽  
Paul Ehrlich ◽  
Erin Thanik ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Withdrawal Syndrome ◽  
Medical Condition ◽  
Skin Lesions ◽  
High Dose ◽  
Topical Steroids ◽  
Rapid Improvement ◽  
Corticosteroid Withdrawal ◽  
Severe Eczema

Abstract Rationale We recently showed that multicomponent traditional Chinese medicine (TCM) therapy had steroid-sparing effects in moderate-to-severe eczema. We sought to evaluate TCM effects in severe eczema in a 7-year-old male with refractory disease and corticosteroid withdrawal syndrome. Methods Prior to referral, the patient had been treated since infancy with increasingly intensive standard of care, including high-dose topical and systemic corticosteroid and antibiotic therapy and was unable to tolerate further steroid treatment. The patient was administered a combination of oral and topical TCM for 17 months following discontinuation of his steroid regimen. His overall medical condition was assessed by SCORAD criteria and laboratory evaluations of serum IgE, absolute eosinophil count, and liver and kidney function tests. Results The patient showed rapid improvement of clinical measures of disease after starting TCM therapy, with marked improvement of sleep quality within the first week, complete resolution of itching, oozing, and erythema at 2 weeks, and a 79% and 99% decrease in his SCORAD values after one month and 3–6 months of TCM, respectively. Serum total IgE decreased by 75% (from 19,000 to 4630 (kIU/L), and absolute eosinophil counts decreased by 60% (from 1000 to 427 cells/μL) after 12 months of treatment. The patient did not require oral or topical steroids during the 17-month trial of TCM. TCM was tapered without complications. His dermatologic manifestations continued to be well-controlled 3 months after discontinuation. Conclusion This case study suggests TCM should be further evaluated in controlled clinical studies of patients with severe, refractory eczema and steroid withdrawal syndrome.

scholarly journals Mingjing Granule, a Traditional Chinese Medicine in the treatment of neovascular age-related macular degeneration: study protocol for a randomized controlled trial

2020 ◽  
Author(s):  
Yamin Li ◽  
Lina Liang ◽  
Torkel Snellingen ◽  
Kai Xu ◽  
Yun Gao ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Macular Degeneration ◽  
Vision Loss ◽  
Controlled Trial ◽  
Age Related Macular Degeneration ◽  
Double Blind ◽  
Anti Vegf ◽  
Age Related ◽  
Function Test

Abstract BackgroundNeovascular age-related macular degeneration (nAMD) is the most common cause of irreversible vision loss and blindness among the elderly people aged 50 and over. Although anti-vascular endothelial growth factor(anti-VEGF) therapies have resulted in improving patient outcomes, there are limitations associated with these treatments. In China, Traditional Chinese medicine(TCM) has been used to treat eye diseases for more than 2000 years. Previous studies have shown that TCM may be beneficial for nAMD patients. However, explicit evidence has not been obtained. The purpose of the present trial is to examine the efficacy and safety of the Mingjing Granule, a compound Chinese herbal medicine, for nAMD patients. Methods/DesignThis is a double-blind, placebo-controlled, randomized trial of Mingjing Granule as an add-on to intravitreous ranibizumab for nAMD. 180 nAMD patients from six hospitals in China will be enrolled according to the inclusion and exclusion criteria, and randomly allocated into two groups, 90 in each. All participants will receive a 24-week treatment and then be followed-up for another 24 weeks. The primary outcome is the mean change of best-corrected visual acuity at week 24 and 48 as compared to the baseline. The secondary outcomes include mean change in central retinal thickness, area of retinal hemorrhage and exudation, and TCM syndrome score, mean number of intravitreal ranibizumab injection and total cost of the treatment. Indexes of safety include blood regular test, urine regular test, liver function test, renal function test and electrocardiogram from baseline to week 24 and 48. Qualitative control and some standard operating processes will be formed throughout the trial. Any ocular or systemic adverse events will be treated suitably and related data will be recorded accurately and completely in the case report form.DiscussionBased on previous empirical and animal laboratory studies, this study will address the question of whether Mingjing Granule could contribute to improving efficacy, safety and efficiency with need for fewer intravitreal injections of anti-VEGF, improving compliance and visual outcomes in the management of persons with nAMD.Trial registrationChinese Clinical Trial Registry (http://www.chictr.org.cn), ChiCTR2000035990. Registered on 21 August 2020.

Well-being is protective for eye pain: Web-based analysis during COVID-19 pandemic (Preprint)

2020 ◽  
Author(s):  
Motoko Kawashima ◽  
Ryutaro Yamanishi ◽  
Miki Uchino ◽  
Emi Ooe ◽  
Kazuo Tsubota
Keyword(s):  
Risk Factors ◽  
Close Association ◽  
Well Being ◽  
Eye Disease ◽  
Ocular Pain ◽  
Lifestyle Habits ◽  
Web Based ◽  
Eye Pain ◽  
History Of ◽  
Pain Symptoms

BACKGROUND The close association between psychological discomfort, poor coping mechanisms, and chronic eye pain has been reported. Mindfulness based intervention is a notable approach for pain with introspection. A healthy mind is important for coping with pain, however the relationship between pain and a healthy mind remains unclear. OBJECTIVE We therefore, investigated the risk factors for eye pain focusing on personal life style, and analyzed the changes in eye pain during the coronavirus disease (COVID-19) pandemic. METHODS A web-based analysis for eye pain was conducted. Age (20 to 69 years), sex, and the presence of dry eye disease (DED) were the criteria used to match a total of 1040 participants (men, 520; women, 520) who were included in the study. The prevalence of DED was 50% in both sexes. We investigated the risk factors for eye pain, and factors for the change in severity of eye pain during the COVID-19 pandemic as well. The participants answered a survey and provided information for the analyses including: demographics, history of eye disease, neuropathic ocular pain symptoms, happiness score, healthiness, life confidence, life satisfaction, interest in healthy eating, custom of eating breakfast; and change of eye pain, lifestyle habits, and happiness degree during the COVID-19 self-restraint period. RESULTS Four hundred ninety-four participants (47.5%) were having eye pain, and 546 participants (52.5%) were not. The multivariate analysis showed age (OR = 1.02; 95% CI = 1.01–1.03), DED (OR = 4.65; 95% CI = 3.48–6.22), and neuropathic ocular pain components (OR=3.53; 95% CI = 2.63–4.75) were risk factors, and high health status (OR = 0.76; 95% CI = 0.57–1.01) were protective for eye pain. Happiness score (OR = 7.96; 95% CI = 2.55–24.87), and improving life happiness during the COVID-19 pandemic self-restraint period, (OR=6.22; 95% CI = 2.02–19.09) were significant factors for improving eye pain during COVID-19 self-restraint period. CONCLUSIONS Possessing well-being is a lifestyle habit that is protective against eye pain. Having better lifestyle habits during the COVID-19 self-restraint period also improved eye pain. Regardless of this unprecedented situation, well-being is protective against eye pain. CLINICALTRIAL NA

Sign in / Sign up

Export Citation Format

Share Document